Masahiro Ikejiri et al.
Bioorganic & medicinal chemistry letters, 17(9), 2470-2473 (2007-03-06)
Nucleoside analogues that have 6-chloropurine as the nucleobase were synthesized and evaluated for anti-SARS-CoV activity by plaque reduction and yield reduction assays in order to develop novel anti-SARS-CoV agents. Among these analogues, two compounds, namely, 1 and 11, exhibited promising